Some studies particularly in Sweden were done but still nobody can say Diabetes vaccine is produced.
How bacteria and/or transplantation influences on vaccine producing?
to prophilaxy or even prevent Diabetes,Specially among high risk subjects.
regards
Vaccination is the control of disease through prophylaxis against the antigen, Type 1 diabetes is an autoimmune disease that could benefit from the therapeutic potential of vaccination
Developing an immune vaccine is never an easy task, especially when it comes to induce tolerance against a self antigen.
If you are interested to learn more on the topic you may follow the research of Professor Len Harisson at the Walter and Eliza Hall Institute (http://wehi.edu.au/faculty_members/professor_len_harrison) who is working on different approaches to cure diabetes and contributed to the development of a nasal insulin vaccine that went into clinical trial.
Researchers in Finland could be close to a breakthrough in the search for a vaccine against Type 1 diabetes. Clinical trials could start soon.
A team working at Tampere University has discovered the virus that causes type 1 diabetes. The enterovirus penetrates the pancreas and destroys insulin-producing cells, eventually causing diabetes.
Researchers have looked at more than a hundred different strains of the virus and pinpointed five that could cause diabetes. They believe they could produce a vaccine against those strains.
”We have identified one virus type that carries the biggest risk,” said professor Heikki Hyöty. ”A vaccine could also protect against its close relatives, to give the best possible effect.”
Ready to test on humans
A similar enterovirus causes polio, which has been almost eradicated in many parts of the world thanks to vaccination programmes. A prototype diabetes vaccine has already been produced and tested on animals.
”We know that this vaccine is effective in mice,” noted Hyöty. ”It is important to test it in people, so that we can be sure that the vaccine prevents diabetes.”
Taking the vaccine through a clinical trial would cost some 700 million euros. Some funding is in place from the United States and from Europe, but more is required.
”Money is the biggest obstacle to testing in humans at the moment,” said Hyöty. ”The matter is of international interest, and people are interested in us. I’m optimistic that the funding will come.”
- Badges
- Science topic
- Similar topics
- Biological Science
- Immunology